02006nas a2200301   4500000000100000008004100001260001200042653001200054653001700066653003400083653001100117100002100128700001500149700001400164700001400178700001600192700001200208700002000220700001300240700001900253700001600272245019300288856006700481300000800548490000600556520112800562022001401690       2024                            d  bMDPI AG10aLeprosy10aDisabilities10aEarly Diagnosis and Treatment10aGuinea1 aIbrahima Sory SS1 aSidikiba S1 aDelphin K1 aMamadou C1 aFatoumata S1 aSadan S1 aMahamoud Sama C1 aSékou D1 aAbdoul Karim N1 aAlexandre D00aFrequency and Factors Associated with Disabilities among Leprosy Patients Admitted to the Kindia Disability Prevention and Physical Rehabilitation Centre (Pirp) in Guinea from 2017 to 2021  uhttps://www.mdpi.com/2414-6366/9/10/237/pdf?version=1728640724  a1-90 v93 a<p>This study aims to estimate the prevalence and analyze the factors associated with leprosy-related disabilities at the Kindia Disability Prevention and Physical Rehabilitation Centre (PIRP) in Guinea. It is a cross-sectional study using routine data from the centre from 2017 to 2021. Of 115 patients, 76% had a disability, 49% of which were grade II and 27% grade I. The age range of 15 to 30 years was the most represented (43.5%), with the average age (standard deviation) being 38 (16.5) years. Children under 14 years of age represented 3.5% of the total. Most (89%) patients had newly diagnosed leprosy. The majority (66.1%) had never come in contact with people with leprosy symptoms. Almost all (99.1%) patients had type 1 reactions on admission. Patients with multibacillary leprosy were in the majority (83.5%), and those with symptoms lasting 7–12 months represented 56.5% of the sample. In total, 79.1% of the patients received corticosteroid therapy, and 92.1% were reported cured at discharge. This neglected tropical disease continues to be a challenge in Guinea, even though leprosy care is free.</p>
  a2414-6366